Thanunrat Thongmee
Overview
Explore the profile of Thanunrat Thongmee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
629
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wanlapakorn N, Suntronwong N, Kanokudom S, Assawakosri S, Vichaiwattana P, Klinfueng S, et al.
Heliyon
. 2024 Nov;
10(21):e39889.
PMID: 39524738
Background: Limited data exists regarding population immunity against diphtheria, tetanus, and pertussis in Thailand during the post-COVID-19 pandemic period. This study aimed to evaluate the age-specific seroprevalence of anti-diphtheria toxoid...
2.
Sarawanangkoor N, Wanlapakorn N, Srimuan D, Thatsanathorn T, Thongmee T, Poovorawan Y
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066382
In 2014, the Expanded Program on Immunization of Thailand changed the timing of the second dose of the measles-mumps-rubella (MMR) vaccine from 4-6 years to 2.5 years, while maintaining the...
3.
Thongmee T, Chansaenroj J, Klinfueng S, Aeemjinda R, Wanlapakorn N, Poovorawan Y
Hum Vaccin Immunother
. 2024 Jul;
20(1):2367283.
PMID: 39051458
As of 2024, Thailand has not incorporated the varicella-zoster virus (VZV) vaccine into the Expanded Program on Immunization (EPI). This study aimed to evaluate VZV seroprevalence across all age groups...
4.
Wanlapakorn N, Sarawanangkoor N, Srimuan D, Thatsanathorn T, Thongmee T, Poovorawan Y
Hum Vaccin Immunother
. 2024 May;
20(1):2352909.
PMID: 38752802
Thailand has incorporated the whole-cell (wP) pertussis vaccine into the expanded program on immunization since 1977 and has offered the acellular pertussis (aP) vaccine as an optional vaccine for infants...
5.
Suntronwong N, Kanokudom S, Auphimai C, Thongmee T, Assawakosri S, Vichaiwattana P, et al.
Vaccines (Basel)
. 2024 Feb;
12(2).
PMID: 38400163
Numerous studies have largely focused on short-term immunogenicity in recovered individuals post mRNA vaccination. However, understanding the long-term durability, particularly in inactivated and adenoviral vectored vaccines, remains limited. We evaluated...
6.
Assawakosri S, Kanokudom S, Suntronwong N, Chansaenroj J, Auphimai C, Nilyanimit P, et al.
Heliyon
. 2024 Jan;
10(1):e23892.
PMID: 38226248
Background: Several countries have authorized a booster vaccine campaign to combat the spread of COVID-19. Data on persistence of booster vaccine-induced immunity against new Omicron subvariants are still limited. Therefore,...
7.
Sintusek P, Buranapraditkun S, Khunsri S, Thongmee T, Vichaiwattana P, Polsawat W, et al.
JPGN Rep
. 2023 Nov;
4(4):e373.
PMID: 38034438
Objectives: According to our previous study, the 2-dose-BNT162b2 vaccination is less effective against the Omicron variant. This study aimed to assess the safety and efficacy of a 3-dose-BNT162b2 vaccination in...
8.
Suntronwong N, Kanokudom S, Thatsanathorn T, Thongmee T, Sudhinaraset N, Wanlapakorn N, et al.
Hum Vaccin Immunother
. 2023 Nov;
19(3):2283916.
PMID: 38014687
Heterologous vaccination with inactivated vaccine followed by adenoviral vector-based vaccine has shown superiority in enhancing immune response compared to homologous primary series. However, data comparing immunity decline after a third...
9.
Sintusek P, Khunsri S, Chansaenroj J, Thongmee T, Poovorawan Y
Pediatr Transplant
. 2023 Nov;
28(1):e14642.
PMID: 37947005
Background: The hepatitis E virus (HEV) infection typically causes acute and self-limiting hepatitis. However, chronic infection can occur in immunocompromised hosts. This study determined the prevalence and impact of HEV...
10.
Chansaenroj J, Suntronwong N, Kanokudom S, Assawakosri S, Vichaiwattana P, Klinfueng S, et al.
Sci Rep
. 2023 Sep;
13(1):15595.
PMID: 37730917
Seroprevalence studies on SARS-CoV-2 are essential for estimating actual prevalence rates of infection and vaccination in communities. This study evaluated infection rates based on total anti-nucleocapsid immunoglobulin (N) and/or infection...